Eczema: Clinical Trials

7 terminated. 7 Phase 3, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	7	Terminated 7
Phase 2	1	Terminated 1

Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Rocatinlimab, Placebo - Atopic Dermatitis	Phase 3	Terminated	Amgen	2621	2023-05-31	2026-07-16
A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection etrasimod, Placebo - Atopic Dermatitis, Atopic Dermatitis, Unspecified	Phase 2 / Phase 3	Terminated	Pfizer	58	2023-01-18	2025-05-08
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream - Pruritus, Atopic Dermatitis	Phase 3	Terminated	Cara Therapeutics, Inc.	287	2022-08-16	2024-02-22
A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis Crisaborole 2% - Atopic Dermatitis	Phase 3	Terminated	Pfizer	40	2020-09-14	2021-08-12
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) Tradipitant, Placebo - Atopic Dermatitis	Phase 3	Terminated	Vanda Pharmaceuticals	87	2019-10-21	2024-05-14
Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema Fucicort® Lipid cream, Fucidin® cream, Fucicort® Lipid cream vehicle - Infected Atopic Dermatitis/Eczema	Phase 3	Terminated	LEO Pharma	68	2018-07-31	2025-02-24
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis Baricitinib - Atopic Dermatitis	Phase 3	Terminated	Eli Lilly and Company	374	2018-06-27	2022-11-08

Narrower conditions

Dermatitis, Atopic (6)  ·  Pruritus (1)

Broader conditions

Dermatitis (7)  ·  Skin Diseases (7)  ·  Skin Diseases, Eczematous (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Genetic Diseases, Inborn (6)  ·  Hypersensitivity (6)  ·  Hypersensitivity, Immediate (6)  ·  Immune System Diseases (6)  ·  Skin Diseases, Genetic (6)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Skin Manifestations (1)

Interventions

Betamethasone (1)  ·  KHK4083 (1)  ·  baricitinib (1)  ·  difelikefalin (1)  ·  etrasimod (1)

Sponsors

Pfizer (2)  ·  Amgen (1)  ·  Cara Therapeutics, Inc. (1)  ·  Eli Lilly and Company (1)  ·  LEO Pharma (1)  ·  Vanda Pharmaceuticals (1)

Countries

United States (5)  ·  Canada (3)  ·  China (2)  ·  Czechia (2)  ·  Japan (2)  ·  Poland (2)  ·  Puerto Rico (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Croatia (1)

Results publications

PMID 33826132, PMID 36749121